High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH₂) receptor requires the hydroxyl group of Tyr-318 on transmembrane helix 5

Article English OPEN
Weaver, RE ; Mobarec, JC ; Wigglesworth, MJ ; Reynolds, CA ; Donnelly, D (2017)
  • Publisher: Elsevier

TIP39 (“tuberoinfundibular peptide of 39 residues”) acts via the parathyroid hormone 2 receptor, PTH₂, a Family B G protein-coupled receptor (GPCR). Despite the importance of GPCRs in human physiology and pharmacotherapy, little is known about the molecular details of the TIP39-PTH₂ interaction. To address this, we utilised the different pharmacological profiles of TIP39 and PTH(1-34) at PTH₂ and its related receptor PTH₁: TIP39 being an agonist at the former but an antagonist at the latter, while PTH(1-34) activates both. A total of 23 site-directed mutations of PTH₂, in which residues were substituted to the equivalent in PTH₁, were made and pharmacologically screened for agonist activity. Follow-up mutations were analysed by radioligand binding and cAMP assays. A model of the TIP39-PTH₂ complex was built and analysed using molecular dynamics. Only Tyr318-Ile displayed reduced TIP39 potency, despite having increased PTH(1-34) potency, and further mutagenesis and analysis at this site demonstrated that this was due to reduced TIP39 affinity at Tyr318-Ile (pIC50 = 6.01±0.03) compared with wild type (pIC₅₀ = 7.81±0.03). The hydroxyl group of the Tyr-318’s side chain was shown to be important for TIP39 binding, with the Tyr318-Phe mutant displaying 13-fold lower affinity and 35-fold lower potency compared with wild type. TIP39 truncated by up to 5 residues at the N-terminus was still sensitive to the mutations at Tyr-318, suggesting that it interacts with a region within TIP39(6-39). Molecular modelling and molecular dynamics simulations suggest that the selectivity is based on an interaction between the Tyr-318 hydroxyl group with the carboxylate side chain of Asp-7 of the peptide.
  • References (32)
    32 references, page 1 of 4

    [1] A. Dobolyi, E. Dimitrov, M. Palkovits, T.B. Usdin, The neuroendocrine functions of the parathyroid 2 receptor, Frontier in Endocrinology 3 (2012) 1-10.

    [2] C. Bergwitz, T.J. Gardella, M.R. Flannery, J.T. Potts, H.M. Kronenberg, S.R. Goldring, H. Jüppner, Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin - evidence for a common pattern of ligand-receptor interaction, J. Biol. Chem. 271 (1996) 26469-26472.

    [3] M. Castro, V.O. Nikolaev, D. Palm, M.J. Lohse, J.P. Vilardaga, Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism, Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 16084-16089.

    [4] A.A. Pioszak, H.E. Xu, Molecular recognition of parathyroid hormone by its G protein-coupled receptor, Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5034-5039.

    [5] K. Hollenstein, J. Kean, A. Bortolato, R.K.J. Cheng, A.S. Doré, A. Jazyeri, R.M. Cook, M. Weir, F.H. Marshall, Structure of class B GPCR corticotropin-releasing factor receptor 1, Nature 449 (2013) 438-443.

    [6] F.Y. Siu, M. He, C. de Graffe, G.W. Han, D. Yang, Z. Zhang, C. Zhou, Q. Xu, D. Wacker, J.S. Joseph, W. Liu, J. Lau, V. Cherezov, V. Katritch, M.W. Wang, R.C. Stevens, Structure of the human glucagon class B G-protein-coupled receptor 1, Nature 449 (2013) 444-449.

    [7] A. Jazayeri, A.S. Dore, D. Lamb, H. Krishnamurthy, S.M. Southall, A.H. Baig, A. Bortolato, M. Koglin, N.J. Robertson, J.C. Errey, S.P. Andrews, I. Teobald, A.J.H. Brown, R. Cooke, M. Weir, F.H. Marshall, Extra-helical binding site of a glucagon receptor antagonist, Nature 533 (2016) 274-277.

    [8] A. Bisello, A.E. Adams, D.F. Mierke, M. Pellegrini, M. Rosenblatt, L. Suva, M. Chorev, Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies, J. Biol. Chem. 273 (1998) 22498-22505.

    [9] V. Behar, A. Bisello, G. Bitan, M. Rosenblatt, M. Chorev, Photoaffinity crosslinking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor, J. Biol. Chem. 275 (2000) 9-17.

    [10] P. Monaghan, B.E. Thomas, I. Woznica, A. Wittelsberger, D.F. Mierke, M. Rosenblatt, Mapping peptide hormone-receptor interactions using a disulfidetrapping approach, Biochemistry 47 (2008) 5889-5895.

  • Bioentities (2)
    1gea Protein Data Bank
    3c4m Protein Data Bank
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    White Rose Research Online - IRUS-UK 0 4
Share - Bookmark